Akero Therapeutics Inc. (AKRO)
NASDAQ: AKRO
· Real-Time Price · USD
49.42
-0.67 (-1.34%)
At close: Aug 15, 2025, 3:59 PM
48.69
-1.48%
After-hours: Aug 15, 2025, 07:10 PM EDT
Akero Therapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -15.46 | -11.25 | -7.01 | -6.85 | -7.15 | -6.69 | -5.89 | -17.73 | -19.48 | -19.22 | -31.27 | -9.41 | -3.05 | -4.77 | -5.69 | -8.01 | -7.46 | -16.7 |
PEG Ratio | 3.48 | 1.24 | 1.23 | -0.23 | 0.72 | 0.74 | -0.15 | -0.97 | -0.97 | -1.41 | 0.61 | -0.52 | -0.75 | 0.23 | -0.17 | 0.51 | -0.08 | 0.33 |
PS Ratio | n/a | n/a | 490.84K | n/a | n/a | n/a | 4.58K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 4.25 | 2.94 | 2.62 | 2.70 | 2.01 | 1.69 | 2.43 | 4.82 | 3.93 | 5.86 | 7.85 | 3.83 | 2.25 | 3.39 | 4.36 | 3.92 | 3.92 | 4.10 |
P/FCF Ratio | -90.38 | -47.06 | -29.26 | -28.29 | -27.4 | -40.62 | -26.75 | -56.58 | -108.17 | -72.92 | -100.46 | -53.46 | -17.14 | -21.71 | -27.64 | -53.35 | -43.11 | -54.94 |
P/OCF Ratio | -90.38 | -47.06 | -29.26 | -28.29 | -27.88 | -40.62 | -26.75 | -56.58 | -108.17 | -72.92 | -100.46 | -53.46 | -17.14 | -21.71 | -27.64 | -53.35 | -43.11 | -54.94 |
OCF/S Ratio | n/a | n/a | -16.77K | n/a | n/a | n/a | -171.22 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.04 | 0.03 | 0.05 | 0.05 | 0.05 | 0.04 | 0.05 | 0.04 | 0.04 | 0.09 | 0.03 | 0.03 | 0.07 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Quick Ratio | 12.66 | 16.80 | 19.38 | 17.25 | 24.89 | 30.12 | 29.27 | 20.25 | 29.78 | 20.84 | 18.61 | 14.97 | 6.90 | 7.60 | 7.70 | 9.42 | 14.35 | 25.23 |
Current Ratio | 12.66 | 16.80 | 19.38 | 17.25 | 24.89 | 30.12 | 29.27 | 20.25 | 29.78 | 20.84 | 18.61 | 14.97 | 6.90 | 7.60 | 7.70 | 9.42 | 14.35 | 25.23 |
Asset Turnover | n/a | n/a | 0.00 | n/a | n/a | n/a | 0.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | -69 | 70.09 | -65.02 | -65.57 | -53.4 | -60.5 | -68.98 | -52.49 | -41.57 | -62.92 | -70.22 | -111.39 | -520.64 | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -0.07 | -0.07 | -0.09 | -0.1 | -0.07 | -0.06 | -0.1 | -0.07 | -0.05 | -0.08 | -0.06 | -0.1 | -0.18 | -0.18 | -0.19 | -0.12 | -0.13 | -0.06 |
Return on Assets | -0.06 | -0.06 | -0.08 | -0.09 | -0.06 | -0.06 | -0.1 | -0.06 | -0.05 | -0.07 | -0.06 | -0.09 | -0.15 | -0.15 | -0.17 | -0.11 | -0.12 | -0.06 |
Return on Invested Capital | -0.08 | -0.07 | -0.1 | -0.11 | -0.08 | -0.07 | -0.11 | -0.08 | -0.06 | -0.08 | -0.07 | -0.1 | -0.17 | -0.18 | -0.19 | -0.12 | -0.13 | -0.06 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | 0.26 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | -6.1 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | 0.50 | n/a | n/a | n/a | -0.01 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | -17.51K | n/a | n/a | n/a | -194.32 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | -17.51K | n/a | n/a | n/a | -194.32 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | -19.51K | n/a | n/a | n/a | -217.86 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | -17.2K | n/a | n/a | n/a | -191.15 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |